Vance Brabham, MD
Vascular Surgery · Greensboro, NCNPI 1447472071
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (45.6%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 31 manufacturers reported payments, led by Cvrx, Inc. at 33.5% of the total.
Across 286 payments — averaging $54.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cvrx, Inc.$5K
- W. L. Gore & Associates, Inc.$4K
- Shockwave Medical, Inc$3K
- Boston Scientific$671
- Inari Medical, Inc.$563
- Angiodynamics, Inc.$299
- plus $2K from 25 others
Across 63 payments — averaging $1290.23 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Surmodics, Inc.$70K
- W. L. Gore & Associates, Inc.$7K
- Bard Peripheral Vascular, Inc.$5K
What the payments were for
- Consulting fees$6,60042%
- Travel & lodging$1,91712%
- Food & beverage$7,14046%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cvrx, Inc. | 33 | $5,242 |
| W. L. Gore & Associates, Inc. | 106 | $3,914 |
| Shockwave Medical, Inc | 7 | $3,043 |
| Boston Scientific | 36 | $671 |
| Inari Medical, Inc. | 21 | $563 |
| Angiodynamics, Inc. | 8 | $299 |
| Medtronic(2 entities) | 5 | $267 |
| Stryker | 3 | $205 |
| Amgen | 11 | $188 |
| Silk Road Medical, Inc. | 4 | $181 |
| Cook Medical LLC | 10 | $153 |
| Livanova USA, Inc. | 5 | $117 |
| Abbott | 4 | $116 |
| Edwards Lifesciences | 3 | $83 |
| Kerecis Limited | 3 | $82 |
| Chiesi USA, Inc. | 1 | $78 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 4 | $68 |
| Novartis | 5 | $67 |
| Johnson & Johnson | 3 | $60 |
| Cardiovascular Systems Inc. | 3 | $47 |
| Janssen Scientific Affairs, LLC | 1 | $37 |
| Aroa Biosurgery Incorporated | 1 | $24 |
| Dilon Technologies, Inc. | 1 | $24 |
| Acell, Inc. | 1 | $23 |
| Davol Inc. | 1 | $18 |
| Haemonetics Corporation | 1 | $17 |
| Argon Medical Devices, Inc. | 1 | $15 |
| BD | 1 | $15 |
| Biom'up France SAS | 1 | $14 |
| Covidien LP | 1 | $14 |
| AstraZeneca | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Barostim Neo System$4,648
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$2,951
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$817
- GORE EXCLUDER AAA Endoprosthesis$473
- GORE TAG Conformable Thoracic Endoprosthesis$316
- ENDURANT IIS$193
- CLOTTRIEVER BOLD CATHETER$164
- Conformable TAG Thoracic Endoprosthesis$150
- GORE VIABAHN Endoprosthesis$141
- GORE VIABAHN VBX Balloon Expandable Endo$138
- ENHANCE Transcarotid Peripheral Access Kit$129
- ENROUTE .014 Guidewire$129
- ENROUTE Transcarotid Neuroprotection System$129
- ENROUTE Transcarotid Stent$129
- C3 Delivery System$120
- EXCLUDER AAA Endoprosthesis$116
- VenaCure 1470 Pro$116
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$114
How this compares
$15,657 in reported general payments places this provider in the 80th percentile of 119 vascular surgery providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 19 | $10,483 |
| BrilintaTicagrelor | 12 | $5,436 |
| ClopidogrelClopidogrel Bisulfate | 151 | $1,035 |
| Rosuvastatin Calcium | 35 | $494 |
| Cilostazol | 38 | $208 |
| Metoprolol Tartrate | 11 | $15 |
| Lorazepam | 11 | $5 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $60 | $10,48319 claims |
| AstraZenecaBrilinta | $12 | $5,43612 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 119 vascular surgery providers in North Carolina.
Other vascular surgery in Greensboro
- Brian ChenGreensboro$22K
- Tyler BuckleyGreensboro$14K
- Brandon CainGreensboro$7K
- Thomas HawkenGreensboro$5K
- Christopher ClarkGreensboro$3K
- Frank ArkoCharlotte$2.6M
- Erin MurphyCharlotte$598K
- Robert MendesRaleigh$408K
- Ellen DillavouRaleigh$284K
- Mark FarberChapel Hill$245K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.